For example, systemic lupus erythematosus (SLE) CD4+ T cells of lupus-prone mice had enriched OXPHOS and glycolytic pathways and combined treatment with 2-DG and metformin in vivo could normalize metabolism of these CD4+ T cells and reverse biomarkers of the disease (33). The gene discussed is CD4; the disease is systemic lupus erythematosus.